March 18, 2022
Real world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is...
Read article
February 18, 2022
Data is the most crucial asset of any clinical trial and hence, sponsors cannot jeopardize collecting clean...
Read article
February 11, 2022
Adopting data standards such as CDISC in the early phase of clinical drug development contributes to the consolidation...
Read article
February 9, 2022
Data is the cornerstone of any clinical trial and is used to ultimately drive the decision-making process related to...
Read article
September 10, 2020
Single arm trials are emerging as an accepted way of assessing a new treatment intervention. They establish clinical...
Read article
July 23, 2020
Just as there are numerous adaptations that fall within the umbrella of adaptive designs, there are several different...
Read article
June 22, 2020
Cytel scientists recently published a new eBook on synthetic control arms and a new scientific primer for the more...
Read article
June 8, 2020
Cytel has recently published a new ebook on synthetic control arms, and a new scientific primer as well.
Read article
March 5, 2020
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the...
Read article
February 20, 2020
It is widely acknowledged among drug developers that one of their most important assets is the data generated during...
Read article
January 22, 2020
In the quest for clinical success, we all strive for evidence packages of the highest quality. If the clinical data is...
Read article
January 8, 2020
In clinical development, data is the vital ‘foundation’ that supports your programs. To successfully bring a promising...
Read article
